ADIL Adial Pharmaceuticals, Inc PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Adial Pharmaceuticals (ADIL) Stock: Buy, Sell, or Hold?

$5.05
+1.34 (+36.12%) β–²
5d: +22.87% 30d: +21.69% 90d: +53.5%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$3.36 – $4.28
Position: EXTENDED
Forward P/E & Valuation
-0.7x
Next 12M consensus est.
Wall Street Target
$8.33
+65.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.00 / $5.15
Trend: Uptrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: ADIL is 18.0% above its trading range ($4.28). While momentum could continue, risk/reward favors waiting for a pullback.

Get Alerted When ADIL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ADIL is currently trading at $5.05, which is considered extended relative to its 30-day fair value range of $3.36 to $4.28.

Technical Outlook: Technically, ADIL is in a uptrend. The price is approaching resistance at $5.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 36.1% recently.

Market Sentiment: ADIL scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.33 (+65.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $3.36 - $4.28
Company Quality Score 32/100 (SELL)
Volume Confirmation HIGH
Confidence Score 21.1%

Trading Range & Key Levels

30-Day Trading Range $3.36 - $4.28
Current vs Trading Range EXTENDED
Support Level $3.00
Resistance Level $5.15
Current Trend Uptrend
Technical data as of Oct 28, 2026

Quantitative Signal Breakdown

  • BEARISH: Price significantly overextended (+18.0% above its trading range)
  • BEARISH: Weak technical setup (5/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+36.1%)
  • BULLISH: Trading 65.0% below Wall St target ($8.33)
  • WARNING: Composite score 32/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.68
Wall Street Target $8.33 (+65.0%)
Share ADIL Analysis

Share this live ADIL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ADIL)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 29, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits user expresses positivity towards $ADIL, mentioning it as part of their watchlist and praising a small-cap community. No recent news articles were found.
Key Retail Themes: Positive sentiment towards $ADIL Mention of small-cap community
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:58 AM ET
Data refreshes hourly during market hours. Next update: 9:58 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ADIL.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 47 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 31 SELL
BNTX
BioNTech SE
BUY
21 analysts
$114 63 BUY
IRD
Opus Genetics, Inc.
STRONG BUY
18 analysts
$13 43 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 39 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ADIL Research Pages
ADIL Technical Chart ADIL Price Prediction ADIL Intrinsic Value DCF ADIL Earnings Date ADIL Investment Advisor ADIL Fair Price Analyzer ADIL Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals